Chronic liver diseases: From development to novel pharmacological therapies: IUPHAR Review 37
Author:
Affiliation:
1. Newcastle Fibrosis Research Group, Biosciences Institute, Faculty of Medical Sciences Newcastle University Newcastle upon Tyne UK
Publisher
Wiley
Subject
Pharmacology
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/bph.15853
Reference176 articles.
1. Biomarkers of liver fibrosis
2. New drugs for NASH
3. The TGR5 receptor mediates bile acid–induced itch and analgesia
4. THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein‐coupled receptors
5. THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: Catalytic receptors
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Old age as a risk factor for liver diseases: Modern therapeutic approaches;Experimental Gerontology;2023-12
2. Polyphenol content, antioxidant and antiproliferative effects of a plant mixture composed of four medicinal plants with hepatoprotective potential;African Journal of Pharmacy and Pharmacology;2023-10-31
3. Therapeutic targets of fibrosis: Translational advances and current challenges;British Journal of Pharmacology;2023-10-17
4. Model of toxic fibrosis in Wistar rats: morphological and molecular-genetic parameters of the transition point to cirrhosis;Genes & Cells;2023-10-03
5. Cellular and Molecular Mechanisms of Toxic Liver Fibrosis in Rats Depending on the Stages of Its Development;Sovremennye tehnologii v medicine;2023-08-30
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3